EXIT Regulatory Integrity v26.4
Nilus Lab Foundation
Compliance Registry

Regulatory Strategy &
Intended Use

Formalizing the boundaries between predictive manifold modeling and clinical decision-making. Version 26.4 | Build 0x771A GOLD.

Intended Use Statement

The Zenith Institutional Platform is intended solely for Computational Target Prioritization and In-Silico Protocol Optimization in pre-clinical longevity research.

"The system facilitates the identification of high-probability therapeutic targets by modeling transcriptomic trajectories using the Zenith ~285M parameter manifold. It provides a decision-support framework to reduce cycle time in institutional validation."

Regulatory Boundary

Institutional RUO

  • • Manifold Mapping (5,000 HD)
  • • Target Prioritization Scoring
  • • In-Silico Synergy Prediction
  • • Reproducible Run Manifests

Non-Diagnostic

  • • Direct Patient Diagnosis
  • • Therapeutic Prescriptions
  • • Clinical Decision Support
  • • Unvalidated Clinical Endpoints

Status: Research Use Only (RUO). Not for use in human diagnostic procedures.

Institutional Evidence Roadmap

Q1 2026: Institutional Verification

Algorithm Integrity Audit (GOLD)

External audit of Zenith Ultra v26.4 parameter stability. Benchmarked for 99.8% fidelity against the Institutional HCA dataset.

Q2 2026: Analytical Validation

Retrospective Manifold Matching

Publication of cross-dataset validation study comparing Zenith trajectories to dry-lab and wet-lab outcomes.

Institutional Compliance

Data Privacy

GDPR/HIPAA compliant ingestion layers. All institutional training data is anonymized and source-verified.

Quality Management

Internal ISO 13485 framework adoption for the Zenith v26.4 development lifecycle (SDLC).

Institutional Audit

Phase 4 Validated build for Zenith Ultra core architecture.

Diligence Ready

Download the comprehensive regulatory manifest for institutional review.